Sofosbuvir-based regimen for genotype 2 HCV infected patients in Taiwan: A real world experience

BACKGROUND: Sofosbuvir (SOF)-based regimens achieve excellent efficacy and safety in the treatment of chronic hepatitis C (CHC) with various genotypes. There are few real-world instances of the use of SOF-based regimens to treat genotype 2 CHC. This study determines the effectiveness and safety of S...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Autores principales: Tsai, Wei-Lun, Wang, Chih-Feng, Cheng, Jin-Shiung, Chen, Wen-Chi, Bair, Ming-Jong, Lo, Ching-Chu
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6953822/
https://ncbi.nlm.nih.gov/pubmed/31923251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0227424
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares